BRUSSELS (Reuters) - Belgian drugmaker Solvay SA launched a takeover offer for Innogenetics NV on Friday, valuing the maker of disease diagnostic products at 177.6 million euros ($277 million). Sign ...
> A new research report concludes that Gilead may be stealing GlaxoSmithKline's "Best anti-HIV drug maker" crown, thanks to Gilead's drug-combo pill Atripla. The study found that Atripla was the HIV ...
LONDON (MarketWatch) -- Deutsche Bank cut Solvay , the Belgian chemicals and pharmaceuticals firm, to sell from hold, saying that the company's pharma drivers are weakening. The broker told clients ...
LONDON (MarketWatch) -- Pharmaceutical and chemical company Solvay said Friday that third-quarter net profit rose 6% to 187 million euros. Sales rose 5% to 2.3 billion euros, after pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results